Anti-hCD20-mIgA

InvivoGen Kontakt z doradcą
Human CD20 (Rituximab) antibody - Murine IgA
Anti-hCD20-mIgA

Anti-hCD20-mIgA features the constant region of the mouse IgA isotype and the variable region of rituximab.

Rituximab is a mouse/human chimeric monoclonal antibody that targets the CD20 antigen found on the surface of malignant and normal B lymphocytes.

Binding of rituximab to CD20 results in cell destruction through different mechanisms including direct signaling of apoptosis, complement activation and cell-mediated cytotoxicity.

Rituximab has been approved by the FDA for the treatment of various lymphoid malignancies, including B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukaemia.

Anti-hCD20-mIgA was generated by recombinant DNA technology.

It has been produced in CHO cells and purified by affinity chromatography with protein L.

Podobne produkty

Anti-hEGFR isotype family

Anti-hEGFR isotype family

InvivoGen
Więcej
Anti-hRANKL-hIgA2

Anti-hRANKL-hIgA2

InvivoGen
Więcej
CR3022-derived Anti-SARS-CoV-2 RBD mAbs

CR3022-derived Anti-SARS-CoV-2 RBD mAbs

InvivoGen
Więcej